Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation

Emerging Infectious Diseases

Volumn 5, Issue 1, 1999, Pages 150-153

  Meis, Jacques F G M ^a   Ruhnke, Markus ^b   De Pauw, Ben E ^a   Odds, Frank C ^c   Siegert, Wolfgang ^b   Verweij, Paul E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HUMBOLDT UNIVERSITY   (Germany)

^c JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANDIDA DUBLINIENSIS; CANDIDIASIS; CASE REPORT; CHILD; CHRONIC MYELOID LEUKEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; NASOPHARYNX CARCINOMA; NEUTROPENIA; STEM CELL TRANSPLANTATION;

EID: 0032977918     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0501.990119     Document Type: Article

References (8)

1. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowsli HM, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997;24:1122-8.
2. Sullivan DJ, Westerneng TJ, Hayes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995;141:1507-21.
3. Sullivan DJ, Coleman DC. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998;36-329-34.
4. Coleman DC, Sullivan DJ, Bennett DE, Morgan GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997;11:557-67.
5. Schoofs A, Odds FC, Colebunders R, Ieven M, Goossens H. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV infected patients. Eur J Clin Microbiol Infect Dis 1997;16:296-300.
6. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998;36:2093-5.
7. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Wayne (PA): The Committee; 1997.
8. Sullivan D, Coleman D. Candida dubliniensis: an emerging opportunistic pathogen. Curr Top Med Mycol 1997;8:15-25.